Accelerating Belgian health-tech & biopharma innovation

About BioWin
iStock-1093656424-web5

See what’s happening in Wallonia, Belgium

News

Learn more
6

How open innovation is transforming healthcare

In a demanding field like healthcare, innovation can no longer happen in silos. Faced with major challenges – an ageing population, chronic diseases and unequal access to care – open innovation and approaches that promote broader cooperation among various actors in healthcare have become essential. They bring together organisations with complementary expertise and roles: public […]

    Collaboration

05.06.2025

Learn more
BE

Health and innovation: BioWin calls for interregional synergies to elevate Belgium’s role in Europe

    Press release

16.05.2025

Learn more
getty-images-EXn3zNVW5lo-unsplash

BioWin’s 2024 annual report is available

    Corporate

15.05.2025

Learn more
about-quantoom.jpg

VaxThera and Quantoom Biosciences Achieve Breakthrough in Poultry Vaccination Against Highly Pathogenic Avian Influenza (HPAI) Using Quantoom’s N-Force Toolbox for saRNA

    Press release

23.06.2025

Learn more

Hyloris Partners with Kuvatris Therapeutics to Advance Suramin IV Development for Sleeping Sickness, Targeting a Priority Review Voucher

    Press release

23.06.2025

Learn more
Novadip-NVD003-shipped-ready-for-the-implantation-to-the-patient

Novadip receives RMAT designation for NVD003, its regenerative treatment for congenital pseudarthosis of the tibia

    Press release

23.06.2025

Success stories

iStock-1314783908-web
Nuclear Medecine

How ABSCINT is redefining cancer diagnostics

ABSCINT is a molecular imaging company. ABSCINT has two lead programs in clinical stage, one in cardiovascular disease and one in oncology.
20.06.2025
2028

ABSCINT to launch first diagnostics in EU & NA
trasis_2022_closeup_web-34_11
Nuclear Medecine

How Trasis turned teamwork into nuclear medicine innovation

Trasis develops and supplies integrated solutions for radiopharmaceutical production, helping research, industry & hospitals advance nuclear medicine worldwide.
27.05.2025
€72M

Record 2024 sales

Stay informed with the BioWin newsletter

Subscribe

Innovate

Why join BioWin

We help simplify the path to bringing innovative ideas to life. With nearly 20 years of hands-on collaborative innovation experience, we don’t just connect companies, research centers, hospitals, and academic institutions—we’re a true partner, offering real support at every step of the research and development process.

From shaping your project to sourcing its financing and ensuring it stays on track, that’s how we give health-tech and biopharma innovations their greatest chance of success.

Learn more
iStock-542576976

Connect

Why join BioWin

In a bid to increase opportunities for our members in terms of both collaboration and market expansion, we connect them to partners through regular events. We also seek to enhance sector attractiveness to source the future talent needed to create sustainable innovation across the Walloon Region.

 

Learn more
iStock-530685719

Communicate

Why join BioWin

Our targeted communication strategies aim to strengthen Wallonia’s profile, while maximising our members’ presence both locally and globally.

Learn more
getty-images-B1n_PGHf4JA-unsplash

Operating at the epicentre of regional health-tech & biopharma innovation

What we work on

Biopharma

iStock-1289345741

Health-tech

iStock-1125084447-web
  • From championing collaborative innovation to playing a more global role in the implementation of the sector’s industrial policy, making innovation happen is part of our DNA.
  • We aim to increase the competitiveness of the Walloon region in the biopharma and health-tech sectors by identifying and supporting strategic projects and portfolios for the benefit of our members and the patients they serve.
  • BioWin’s network of 260+ world-class organisations is an exceptional ecosystem known for both its academic excellence and robust industrial value chain in biomanufacturing, advanced therapies, nuclear medicine and medical technologies. 

Our ecosystem at a glance

Numbers

Our ecosystem

270

supported organisations

90

supported R&D projects

313,74M

€ raised by our members through public-private funding

12

job offers